Inspira Technologies Oxy B.H.N. Ltd IINN

NAS: IINN | ISIN: IL0011715781   27/06/2025
0,850 USD (+1,80%)
(+1,80%)   27/06/2025

25 maart 2025 · Inspira Technologies Announces Successful Installation of INSPIRA ART100 Systems in Premier U.S. Hospital · Persbericht

19 maart 2025 · Inspira Technologies' Innovative Life-Support System to be Showcased at AmSECT 63rd International Conference 2025 in San Diego · Persbericht

14 maart 2025 · Inspira Technologies Releases CEO Update: Major Milestones Signal Next-Level Respiratory Care · Persbericht

13 maart 2025 · Inspira Technologies Receives Nasdaq Notification Regarding Minimum Bid Requirement · Persbericht

11 maart 2025 · Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates · Persbericht

4 maart 2025 · Inspira Technologies Announces Positive Results from Clinical Study of HYLA Blood Sensor, Achieving 96% Accuracy · Persbericht

13 september 2024 · Inspira™ Secures a Second U.S. Patent Approval for Orbiting Blood Oxygenation Delivery System · Persbericht

28 augustus 2024 · Inspira™ to Publish HYLA™ Clinical Results in Fourth Quarter 2024 · Persbericht

22 augustus 2024 · Inspira™ Technologies Announces FDA Listing and Market Readiness of New Product · Persbericht

13 augustus 2024 · Inspira™ Approached by Large Medical Company to Evaluate Operation of their Key Product with INSPIRA™ ART100 - Results Exceed 100% at Maximum Flow · Persbericht

30 juli 2024 · Inspira™ Technologies Introduces the INSPIRA Cardi-ART, Aiming to Provide Oxygen to the Brain During Cardiac Arrest · Persbericht

11 juli 2024 · Inspira™ Receives Israeli Regulatory Approval for the INSPIRA™ ART100 System · Persbericht

20 juni 2024 · Inspira™ Announces Business Plan Targets · Persbericht

17 juni 2024 · Inspira™ Introduces Advanced Life Support Solutions to Key International Leaders at the Annual iECOs Conference in Israel · Persbericht

13 juni 2024 · Inspira™ Receives First Ever Purchase Order for INSPIRA™ ART100 Systems in the U.S. · Persbericht

5 juni 2024 · Inspira™ to Exhibit the FDA Cleared INSPIRA™ ART100 System at a World-Renowned Event in the Sector · Persbericht

30 mei 2024 · Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments · Persbericht

28 mei 2024 · INSPIRA™ ART100 Receives FDA 510(k) Clearance · Persbericht

2 mei 2024 · Inspira™ Announces Start of Production of the INSPIRA™ ART100 · Persbericht

25 april 2024 · Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100 · Persbericht

Mijn selecties